The
Endocannabinoid System (ECS) is one of the most important components
of the body. The number of physiological processes it is responsible
for or involved in is truly staggering. Understanding the ECS is
important for both cannabis users and non-users alike, as its impact
on health is unparalleled. Given its integral roles in biology, the
ECS appears in many surprising and unexpected places.
The
Endocannabinoid System Promotes Embryonic Development
From
the earliest stages of life, the ECS participates in many critical
life-sustaining functions. Even the successful
implantation of the embryo into
the uterus requires endocannabinoid activity. Interestingly, the CB1
receptor, which is responsible for the psychoactive effects of
cannabis, promotes brain development by regulating the
differentiation of neural progenitor (stem) cells and guiding
synaptogenesis. After birth, endocannabinoid activation of the CB1
receptor initiates milk suckling. The remarkable involvement of the
ECS in development is a testament to how important it is to human
life.
The
time at which the ECS appeared in evolution shows how integral the
system is not just to human life, but higher-level organisms in
general. Due to the presence of cannabinoid receptor-like proteins in
nematodes and sea squirts, it is likely the ECS
began evolving 600
million years ago. Since the ECS is involved in connecting other
bodily systems and facilitating communication, it makes sense the
earliest remnants of it appeared so early in evolution.
Neurons
usually communicate in a one-way direction. Presynaptic neurons
release neurotransmitters that attach to receptors on postsynaptic
neurons. Endocannabinoids go in the reverse direction, travelling
from the postsynaptic neuron to the presynaptic neuron. This process
is known as retrograde feedback and it enables control of neural
transmission. For example, if a neuron is sending messages too
quickly, the receiving neuron can send an endocannabinoid to the
sending neuron telling it to slow down.
The Endocannabinoid System Helps Protect Against Cancer
Cancerous
cells are defined by their tendency to replicate uncontrollably and
spread throughout the body. There are hundreds of different types of
cancer, and while each has distinguishing factors, many similarities
exist as well. For example, many types express cannabinoid receptors
like CB1 and CB2 on their cell membranes. Endocannabinoids like
anandamide bind to these receptors to inhibit
cancer cell growth. The effectiveness of a strong ECS on cancer
survival was described in a 2006 study. Researchers found that
patients with naturally
high expression levels of
CB1 and CB2 receptors had significantly better disease-free survival
than patients with low expression levels.
Despite
its ubiquitous role in human physiology, research
indicating the existence of the ECS was not published until 1992.
This is when the first endogenous, self-made cannabinoid anandamide
was discovered and in subsequent years several other endocannabinoids
have been discovered.
Due
to the novelty of the ECS, most medical schools do not teach much
about it, let alone even give it mention. This is part of the reason
why cannabis medicine has not been more widely accepted within the
mainstream medical community. Thankfully, given the quickly rising
accumulation of scientific and anecdotal evidence, it is only a
matter of time before cannabis is made available as a standard
medication.
No comments:
Post a Comment